DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diatrizoate Meglumine And Diatrizoate Sodium, and when can generic versions of Diatrizoate Meglumine And Diatrizoate Sodium launch?
Diatrizoate Meglumine And Diatrizoate Sodium is a drug marketed by Anda Repository and Annora Pharma and is included in two NDAs.
The generic ingredient in DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diatrizoate Meglumine And Diatrizoate Sodium
A generic version of DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM was approved as diatrizoate meglumine; diatrizoate sodium by ANDA REPOSITORY on June 27th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM?
- What are the global sales for DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM?
- What is Average Wholesale Price for DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM?
Summary for DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 190 |
| DailyMed Link: | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM at DailyMed |
Pharmacology for DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anda Repository | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 214201-001 | Jun 27, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Annora Pharma | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 215049-001 | Nov 17, 2023 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
